![Careers in Discovery](https://pbcdn1.podbean.com/imglogo/image-logo/18676005/1478977-1674819143110-a9f40d319527c.jpg)
1.1K
Downloads
135
Episodes
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
Episodes
![Nara Daubeney, Phaim](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/95fa7aa53f03eaeceef8917150548650_300x300.jpg)
Wednesday Apr 26, 2023
Nara Daubeney, Phaim
Wednesday Apr 26, 2023
Wednesday Apr 26, 2023
"It comes down to [the question], 'Why are you here?'. We looked at this project and thought, if we do this and it works, then we have a therapy that could prevent people from progressing down the inevitable slide into insulin dependence, with all the long term impacts that implies. And that would be a really worthwhile course to take."
Nara Daubeney is the COO of Phaim, a Biotech company using antigenic immune modulation to treat diabetes and other conditions.
Nara joined us to talk about her transition from a successful medical career into the world of start-up Biotech, taking the immune system back to school and why the "fire in your belly" should be your guide.
Enjoy!
![Richard Weaver](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/1a97e7c45df95132f9f947fa43393553_300x300.jpg)
Wednesday Apr 19, 2023
Richard Weaver
Wednesday Apr 19, 2023
Wednesday Apr 19, 2023
"Don't think that just because you've done a Biology or Chemistry degree, this is your path forever....I didn't become an entrepreneur until the age of 42. Your [career] path isn't fixed."
Richard Weaver is a consultant to Biotech companies on their drug development programmes, specialising in DMPK. Before becoming a consultant, Rich was the founder of XenoGesis, a CRO he successfully sold to Sygnature Discovery in 2020.
Rich talked to us about his career as a scientist and an entrepreneur, his formula for building a CRO and the advantages of organic growth.
Enjoy!
![Nuno Madeira do Ó, Reflection Therapeutics](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/a7ab47c78c6fd71bd15f77c577db7bd3_300x300.jpg)
Wednesday Apr 12, 2023
Nuno Madeira do Ó, Reflection Therapeutics
Wednesday Apr 12, 2023
Wednesday Apr 12, 2023
"Anybody can be a pair of hands, follow a protocol and do what they're told. If you want more than that, if you want to be a pair of hands with a brain, then you have to think differently."
Nuno Madeira do Ó is the CEO of Reflection Therapeutics, a Biotech company harnessing the potential of Tregs to treat inflammatory diseases.
Nuno shared the story of his career so far, and among other things we discussed pivoting a Biotech into a new disease area, transitioning from research into commercial roles and how a children's cartoon inspired a career in Life Sciences.
Enjoy!
![Leigh Brody, AlbionVC](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/2263afef4f29c7746196cb1a6b4ddc1d_300x300.jpg)
Wednesday Mar 29, 2023
Leigh Brody, AlbionVC
Wednesday Mar 29, 2023
Wednesday Mar 29, 2023
"We are in such an exciting time in Life Sciences...if you have an idea, go for it, because there's a lot of VC money out there...and the appetite to invest early has improved, so it's the right time to speak to investors about potential ideas."
Leigh Brody is an entrepreneur, executive and now venture investor at AlbionVC, where she oversees the UCL Technology Fund.
Leigh joined us to talk about her career, the difference between a good idea and an investable one and why you must ALWAYS patent your ideas.
Enjoy!
![Samuel Woodhouse, CoSyne Therapeutics](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/d51a042ecdcd2578f030c7552004c955_300x300.jpg)
Wednesday Mar 22, 2023
Samuel Woodhouse, CoSyne Therapeutics
Wednesday Mar 22, 2023
Wednesday Mar 22, 2023
"Join a young company. If you're employee number 10, you're 10% of the business as opposed to 1% in a 100 person company. You will learn way more just by osmosis....if you're curious and ask questions."
Samuel Woodhouse is the VP of Operations at CoSyne Therapeutics, a technology-driven drug discovery company on a mission to reinvent Pharma from the ground up.
Samuel joined us to talk about his career in genomics and start up Biotechs, why academia wasn't for him and why developing people is much more powerful than giving them a payrise.
Enjoy!
![Roland Burli, Cerevance](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/af86932e8be3f362f1ed6fa16ed7d63c_300x300.jpg)
Wednesday Mar 15, 2023
Roland Burli, Cerevance
Wednesday Mar 15, 2023
Wednesday Mar 15, 2023
"In the first few years [of your career], what's really important is to establish yourself. You learn a certain skillset in academia...the next thing is to really apply that in the context of a drug discovery project....if you develop a proven track record as a good scientist, good things will happen."
Roland Burli is the Vice President of Drug Discovery at Cerevance, where he and his team are using a unique platform to develop new treatments for brain diseases.
Roland joined us to discuss his varied career to date, from landing in LA with just a backpack to working for some of the industry's biggest names.
Enjoy!
![Sree Vadlamudi, Iktos](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/82d6a63ae5d026f6786f8e2062c38259_300x300.jpg)
Wednesday Mar 01, 2023
Sree Vadlamudi, Iktos
Wednesday Mar 01, 2023
Wednesday Mar 01, 2023
"[If you receive negative feedback] analyse it in a constructive way, then take away the good points that will help you to move forward. Outside of that, just move on."
Sree Vadlamudi is the Vice President of Business Development for the EU and Rest of World at Iktos, a company using AI to expedite drug discovery.
We talked to Sree about his career move from research into BD and how he approaches prospecting, outreach and relationship building in Biotech.
Enjoy!
![Valentino Parravicini, Oxford Cannabinoid Technologies](https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog18676005/9fc129a6927011329bceda37211b2490_300x300.jpg)
Wednesday Feb 22, 2023
Valentino Parravicini, Oxford Cannabinoid Technologies
Wednesday Feb 22, 2023
Wednesday Feb 22, 2023
"Scientists work on things they can't see and that probably will never work - but they keep going. Resilience is so important in this career."
Valentino Parravicini is the Chief Scientific Officer of Oxford Cannabinoid Technologies, a company harnessing the power of the endocannabinoid system to treat severe, chronic pain.
Valentino joined us to talk about his career in academia, Pharma and Biotech, the 5,000 year history of cannabinoids as medicines, and why EVERY piece of information is important in science.
Enjoy!
![Image](https://pbcdn1.podbean.com/fs1/user-site-dist/assets/customize-component4.png)
Your Title
This is the description area. You can write an introduction or add anything you want to tell your audience. This can help potential listeners better understand and become interested in your podcast. Think about what will motivate them to hit the play button. What is your podcast about? What makes it unique? This is your chance to introduce your podcast and grab their attention.